Protalix

Protalix is a biopharmaceutical company focused on developing, manufacturing, and commercializing recombinant therapeutic proteins using its proprietary ProCellEx plant cell-based expression system. Its commercial portfolio includes enzyme replacement therapies for Gaucher and Fabry disease, and it also advances additional biologic candidates in its pipeline.

Relationship details are part of the Pro plan.